197 related articles for article (PubMed ID: 21167150)
1. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
[TBL] [Abstract][Full Text] [Related]
2. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Sohn EJ; Kim CS; Kim YS; Jung DH; Jang DS; Lee YM; Kim JS
Life Sci; 2007 Jan; 80(5):468-75. PubMed ID: 17070554
[TBL] [Abstract][Full Text] [Related]
3. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
4. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
[TBL] [Abstract][Full Text] [Related]
5. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
[TBL] [Abstract][Full Text] [Related]
6. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.
Rösen P; Wiernsperger NF
Diabetes Metab Res Rev; 2006; 22(4):323-30. PubMed ID: 16444763
[TBL] [Abstract][Full Text] [Related]
7. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
[TBL] [Abstract][Full Text] [Related]
8. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
10. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.
Matafome P; Louro T; Rodrigues L; Crisóstomo J; Nunes E; Amaral C; Monteiro P; Cipriano A; Seiça R
Diabetes Metab Res Rev; 2011 Jan; 27(1):54-62. PubMed ID: 21218508
[TBL] [Abstract][Full Text] [Related]
11. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
12. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
[TBL] [Abstract][Full Text] [Related]
13. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
15. Baicalin upregulates the genetic expression of antioxidant enzymes in Type-2 diabetic Goto-Kakizaki rats.
Waisundara VY; Siu SY; Hsu A; Huang D; Tan BK
Life Sci; 2011 Jun; 88(23-24):1016-25. PubMed ID: 21439975
[TBL] [Abstract][Full Text] [Related]
16. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
[TBL] [Abstract][Full Text] [Related]
17. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
19. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
Yan J; Feng Z; Liu J; Shen W; Wang Y; Wertz K; Weber P; Long J; Liu J
J Nutr Biochem; 2012 Jul; 23(7):716-24. PubMed ID: 21820301
[TBL] [Abstract][Full Text] [Related]
20. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]